Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: case report and review of literature
Background: The most common sites of recurrence after liver transplantation for hepatocellular carcinoma (HCC) have been reported to be the liver, lung, bone, and adrenal glands, but there have also been many reports of cases of multiple recurrence. The prognosis after recurrence is poor, with reported median survival after recurrence of HCC ranging from 9 to 19 months. Here, we report a case of long-term survival after recurrence of pharyngeal metastasis following living-donor liver transplantation (LDLT) for HCC within the Milan criteria, by resection of the metastatic region and cervical lymph node dissection.
Case presentation: A 47-year-old man with a Model End-stage Liver Disease (MELD) score of 11 underwent LDLT for HCC within the Milan criteria for liver cirrhosis associated with hepatitis B virus infection, with his 48-year-old elder brother as the living donor. One year and 10 months after liver transplantation, he visited a nearby hospital with a chief complaint of discomfort on swallowing. A pedunculated polyp was found in the hypopharynx, and biopsy revealed HCC metastasis. We performed pharyngeal polypectomy. Two years later, cervical lymph nodes metastasis appeared, and neck lymph node dissection was performed. Although recurrence subsequently occurred three times in the grafted liver, the patient is still alive 12 years and 10 months after recurrence of pharyngeal metastasis. He is now a tumor-free outpatient taking sorafenib.
Conclusion: It is necessary to recognize that the nasopharyngeal region is a potential site of HCC metastasis. Prognostic improvement can be expected with close follow-up, early detection, and multidisciplinary treatment, including radical resection.
Figure 1
Figure 2
Figure 3
Posted 15 May, 2020
On 03 May, 2020
On 02 May, 2020
On 02 May, 2020
On 12 Apr, 2020
Received 11 Apr, 2020
Received 10 Apr, 2020
Received 06 Apr, 2020
Received 04 Apr, 2020
On 02 Apr, 2020
On 01 Apr, 2020
On 30 Mar, 2020
On 29 Mar, 2020
Invitations sent on 07 Mar, 2020
On 06 Mar, 2020
On 05 Mar, 2020
On 05 Mar, 2020
On 05 Mar, 2020
Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: case report and review of literature
Posted 15 May, 2020
On 03 May, 2020
On 02 May, 2020
On 02 May, 2020
On 12 Apr, 2020
Received 11 Apr, 2020
Received 10 Apr, 2020
Received 06 Apr, 2020
Received 04 Apr, 2020
On 02 Apr, 2020
On 01 Apr, 2020
On 30 Mar, 2020
On 29 Mar, 2020
Invitations sent on 07 Mar, 2020
On 06 Mar, 2020
On 05 Mar, 2020
On 05 Mar, 2020
On 05 Mar, 2020
Background: The most common sites of recurrence after liver transplantation for hepatocellular carcinoma (HCC) have been reported to be the liver, lung, bone, and adrenal glands, but there have also been many reports of cases of multiple recurrence. The prognosis after recurrence is poor, with reported median survival after recurrence of HCC ranging from 9 to 19 months. Here, we report a case of long-term survival after recurrence of pharyngeal metastasis following living-donor liver transplantation (LDLT) for HCC within the Milan criteria, by resection of the metastatic region and cervical lymph node dissection.
Case presentation: A 47-year-old man with a Model End-stage Liver Disease (MELD) score of 11 underwent LDLT for HCC within the Milan criteria for liver cirrhosis associated with hepatitis B virus infection, with his 48-year-old elder brother as the living donor. One year and 10 months after liver transplantation, he visited a nearby hospital with a chief complaint of discomfort on swallowing. A pedunculated polyp was found in the hypopharynx, and biopsy revealed HCC metastasis. We performed pharyngeal polypectomy. Two years later, cervical lymph nodes metastasis appeared, and neck lymph node dissection was performed. Although recurrence subsequently occurred three times in the grafted liver, the patient is still alive 12 years and 10 months after recurrence of pharyngeal metastasis. He is now a tumor-free outpatient taking sorafenib.
Conclusion: It is necessary to recognize that the nasopharyngeal region is a potential site of HCC metastasis. Prognostic improvement can be expected with close follow-up, early detection, and multidisciplinary treatment, including radical resection.
Figure 1
Figure 2
Figure 3